Three-chamber test behavioral outcomes.

Three-chamber test behavioral outcomes.

<p>Individual data points are shown with bars representing group means ± SEM. <b>(a)</b> Social Preference Index was significantly reduced in VPA and VPA-DPO groups compared to Control (<i>p =</i> 0.004, <i>d =</i> 1.1). <b>(b)</b> Time spent in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile nagusia: Ömer Yusuf İpek (22676357) (author)
Beste egile batzuk: Tuğba Kirboğa (22676360) (author), Ercan Babur (22676363) (author), Nurcan Dursun (22676366) (author), Cem Süer (22676369) (author)
Argitaratua: 2025
Gaiak:
Cell Biology
Genetics
Neuroscience
Biotechnology
Developmental Biology
Science Policy
Mental Health
Biological Sciences not elsewhere classified
Chemical Sciences not elsewhere classified
pronounced hematological response
five consecutive days
exposed rats beginning
early brain maturation
disrupt neural development
critical translational challenge
behavioral assessments using
2 &# 8211
postnatal day 21
administered darbepoetin alfa
acting epo analogue
therapeutic timing limitations
postnatal darbepoetin
therapeutic window
timing gap
delayed timing
valproic acid
typically diagnosed
though non
significant improvements
retain efficacy
relevant social
neuroprotective effects
interventions effective
influence neurodevelopment
findings suggest
environmental factors
diagnostic period
complex genetic
cognitive behaviors
chamber test
3 years
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak